Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Search
Our core product areas
Click here to find out about our core product areas for companion animals. These core product areas are parasiticides, vaccines, and pharmaceuticals.
Stroke, Don’t Stay at Home
During COVID-19, there was a decrease in stroke hospital admissions. Learn why it is crucial that patients can still access urgent care at this time.
Boehringer Ingelheim and IIT Kanpur join hands for social impact
Boehringer Ingelheim India to support Lenek Technologies, a startup incubated at SIIC, IIT Kanpur to improve tuberculosis screening through its innovative handheld X-ray device.
COVID-19 PetPro Connect
Our PetPro Connect platform connects veterinarians and pet owners and makes it easy to deliver the collaborative pet care experience pet owners seek.
3 scopes for sustainability Saint Vulbas France
Click here to find out how Boehringer Ingelheim is working to improve the sustainability and biodiversity of the research site at Saint-Vulbas in France.
Kobe
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Kobe site.
CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults
CDSCO approves SPEVIGO® (spesolimab)
Duluth
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Duluth site.
Watch out: the tick season is there!
From a Southern tick species spreading throughout Europe to the fact American pop singer Justin Bieber is battling Lyme disease, ticks are in the news.
Travelling with dogs
What are some of the things we should consider when traveling with dogs? Click here to read our tips for a relaxing trip with your furry companion.
Dortmund
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Dortmund site.
1948-1988
Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Lyon
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
1885-1948
In 1885, Albert Boehringer purchased a small tartar factory in the Rhine-Hessian village of Nieder-Ingelheim. Click here to learn more about our history.
Vienna
Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Vienna site.
COVID-19 Volunteering in the U.S.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Quick response in fighting Foot-and-Mouth-Disease
Colleagues from the Veterinary Public Health helped to contain an outbreak of Foot-and-Mouth Disease (FMD) on the island of Rodrigues in just six days.
COVID-19 Volunteering in Australia and New Zealand
Our employees down under have embraced the opportunity to volunteer their time and skills as part of the company’s COVID-19 Global Support Program.
Shanghai
Shanghai serves as an important hub for all of the company’s three business areas: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
The Angels Initiative – F.A.S.T.
Recognise the symptoms of stroke and seek immediate medical help to improve outcomes. Click here to learn more and find out more information.
Saving Lives
The Angels Initiative celebrates stroke nurses, saving lives “one grandpa at a time”. Click here to learn more and to find out more information.
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. Learn about how we collaborate with patient organisations.